연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
2317. Associations of postmenopausal hormone therapy with metabolic syndrome among diabetic and non-diabetic women.
Kim JE1, Choi J1, Park J1, Lee JK2, Shin A3, Park SM4, Kang D5, Choi JY6.
Maturitas. 2019 Mar;121:76-82. doi: 10.1016/j.maturitas.2018.12.012. Epub 2018 Dec 20. Link
2316. Association between family history of diabetes and clusters of adherence to healthy behaviors: cross-sectional results from the Health Examinees-Gem (HEXA-G) study.
Choi J1, Choi JY1,2,3, Lee SA4, Lee KM5, Shin A2,3, Oh J6, Park J1, Song M2,7, Yang JJ2, Lee JK6,8, Kang D1,3,2,9.
BMJ Open. 2019 Jun 16;9(6):e025477. doi: 10.1136/bmjopen-2018-025477. Link
2315. Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.
Shagera QA1,2, Cheon GJ3,4,5, Koh Y6,7, Yoo MY1,8, Kang KW1,9,6, Lee DS1,9, Kim EE1,10, Yoon SS6,7, Chung JK1,9,6.
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1417-1427. doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2. Link
2314. Efficient Selection of Antibodies Reactive to Homologous Epitopes on Human and Mouse Hepatocyte Growth Factors by Next-Generation Sequencing-Based Analysis of the B Cell Repertoire.
Kim S1,2, Lee H3, Noh J4, Lee Y5, Han H6, Yoo DK7,8,9, Kim H10,11, Kwon S12,13,14,15,16, Chung J17,18,19.
Int J Mol Sci. 2019 Jan 18;20(2). pii: E417. doi: 10.3390/ijms20020417. Link
2313. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus.
Kim KH1,2, Kim J3, Ko M3, Chun JY4, Kim H2, Kim S5, Min JY3, Park WB4, Oh MD4, Chung J1,2,6.
PLoS Pathog. 2019 Feb 1;15(2):e1007375. doi: 10.1371/journal.ppat.1007375. eCollection 2019 Feb. Link
2312. High-throughput retrieval of physical DNA for NGS-identifiable clones in phage display library.
Noh J1, Kim O1,2, Jung Y2, Han H2, Kim JE2, Kim S3,4, Lee S2, Park J2, Jung RH5, Kim SI3,4, Park J2, Han J3,6, Lee H1, Yoo DK3,6,7, Lee AC8, Kwon E2, Ryu T2, Chung J3,4,6, Kwon S1,5,8,9,10.
MAbs. 2019 Apr;11(3):532-545. doi: 10.1080/19420862.2019.1571878. Epub 2019 Feb 12. Link
2311. Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody.
Kim SI1,2, Kim S3,4, Kim J5, Chang SY6, Shim JM7, Jin J8, Lim C9, Baek S10, Min JY11, Park WB12, Oh MD13, Kim S14, Chung J15,16,17.
Int J Mol Sci. 2019 Oct 12;20(20). pii: E5073. doi: 10.3390/ijms20205073. Link
2310. The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab.
Shin JW1,2, Kim S3,4, Ha S5,6, Choi B7, Kim S8, Im SA9,10,11, Yoon TY12, Chung J13,14.
Biomolecules. 2019 Oct 19;9(10). pii: E629. doi: 10.3390/biom9100629. Link
2309. Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids.
Park JY1, Kim YJ2, Lee JY2, Lee YS2, Jeong JM3.
Nucl Med Biol. 2019 Sep - Oct;76-77:28-35. doi: 10.1016/j.nucmedbio.2019.09.003. Epub 2019 Oct 20. Link
2308. Design and synthesis of enantiopure 18 F-labelled [18 F]trifluoromethyltryptophan from 2-halotryptophan derivatives via copper(I)-mediated [18 F]trifluoromethylation and evaluation of its in vitro characterization for the serotonergic system imaging.
Kim HY1, Lee JY1,2, Lee YS1, Jeong JM1,2,3.
J Labelled Comp Radiopharm. 2019 Jul;62(9):566-579. doi: 10.1002/jlcr.3772. Epub 2019 Jun 24. Link